Document Classification

Section Type: RESULTS

Text: Decreases in serum cholesterol (total, 12. 4 + / -3. 1 %, P < 0. 004 ; LDL, 22 + / -3. 9 %, P < 0. 002 ; total/HDL ratio, 15. 2 + / -3. 4 %, P < 0. 003 ; and LDL/HDL ratio, 22. 2 + / -4. 1 %, P < 0. 002), apolipoprotein (apo) B (15. 1 + / -4. 3 %, P < 0. 0004), apo B/A -1 ratio (13. 1 + / -3. 4 %, P < 0. 0003), and serum fructosamine (5. 2 + / -1. 4 %, P < 0. 002) were observed during KJM treatment compared with WB-control.